NasdaqCM:NKTRPharmaceuticals
Nektar Therapeutics MS Collaboration Adds New Angle To Volatile Stock Story
Nektar Therapeutics (NasdaqCM:NKTR) announced a new academic collaboration with neuroimmunologist Dr. Stephen L. Hauser and UCSF focused on multiple sclerosis research.
The partnership aims to integrate clinical insights with foundational neuroscience to explore potential advances in MS treatment for patients worldwide.
Nektar Therapeutics, trading at a recent share price of $70.37, has seen sharp moves in its stock, including an 89.3% return over the past 30 days and a 62.1% return year to...